Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound

Thread starter U.S. News
Start date Dec 18, 2025

U.S. News

Guest

Dec 18, 2025

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound

Prefix: N/A

Forum: USA News

Start date: Dec 18, 2025

Last reply date: Dec 18, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Dec 18, 2025

Replies: 0

Views: 6

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search